CD8A and neoplasm: Anthracyclines trigger immunogenic cell death (ICD), releasing damage-associated molecular patterns (DAMPs) that transform tumor cells into immunogenic entities, recruiting and activating CD8+ cytotoxic T lymphocytes (Kroemer et al., 2013).